AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The true crux of clinical trials.(LETTERS)(Letter to the editor)
Dr. David Orentlicher and Dr. Thomas Kintanar tackled a provocative topic, but missed some important points ("Should patients be required to take part in comparative clinical trials?" Pro & Con, Nov. 15, 2005, p. 5).
Refusal by eligible subjects to participate is only one impediment to completing useful trials, and certainly not always the major one. Arguably, the conduct of important trials is more commonly limited by insufficient government and industry funding; scarcity of appropriately trained clinical scientists, biostatisticians, and support personnel; and disinterest or prejudice of physicians themselves. Dr. Kintanar correctly emphasized that the best way to correct poor participation rates is to optimize communication during the consent process.
Requiring participation is justified as a means to evaluate potentially life-saving but time-sensitive therapies for emergency conditions when no other ...
- EPIX Pharmaceuticals Presents Findings from PRX-08066 Clinical Trials at...
- Press release article from: Business Wire December 7, 2006 700+ words
...controlled Phase 1 clinical trials of PRX-08066...Therapeutics meeting at the National Institutes of Health in Bethesda...from two Phase 1 clinical trials with PRX-08066...candidates currently in clinical trials targeting conditions...
- CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes...
- Newspaper article from: Cancer Weekly July 21, 2009 700+ words
...response against his/her tumor. Dr. Talor will also discuss the clinical findings from the different Multikine Phase II clinical trials which highlight the advantages that Multikine treatment provides for early disease management in newly diagnosed (treatment...
- CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes...
- Press release article from: PR Newswire July 10, 2009 700+ words
...response against his/her tumor. Dr. Talor will also discuss the clinical findings from the different Multikine Phase II clinical trials which highlight the advantages that Multikine treatment provides for early disease management in newly diagnosed (treatment...
- Norzyme(TM) Clinical Trials On HIV-AIDS Patients Underway; National Institutes...
- Press release article from: PR Newswire November 4, 2002 700+ words
...technology for use at point-of-care, has launched clinical trials for its Levoprin-ZG(TM) product, developed to aid...federal funding awards of more than $1.6 million from the National Institutes of Health, and the presentation of two posters at the...
- AIDS vaccine developed at Emory, NIH moves to clinical trials.(Emory University...
- Newspaper article from: AIDS Weekly February 10, 2003 700+ words
...Laboratory of Viral Diseases at the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), has begun a Phase I clinical trial. A total of 30 human volunteers will be enrolled at the...
- The University of Maryland school of medicine has been awarded $23.7 million by...
- Magazine article from: Diverse Issues in Higher Education January 10, 2008 700+ words
The UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE has been awarded $23.7 MILLION by the National Institutes of Health to conduct clinical trials of vaccines and therapies for infectious diseases. The finds will be distributed over seven years.
- VIMRx Pharmaceuticals announce National Institutes of Health (NIH) sponsorship...
- Press release article from: PR Newswire August 20, 1990 700+ words
...PHARMACEUTICALS ANNOUNCES NATIONAL INSTITUTES OF HEALTH (NIH) SPONSORSHIP OF PHASE I CLINICAL TRIALS OF HYPERICIN IN...the Phase I human clinical trials of Hypericin in...conducted by the AIDS Clinical Trials Group (ACTG) of...
- Norzyme(TM) Awarded Grant by National Institutes of Health; Million Dollar...
- Press release article from: PR Newswire August 14, 2002 700+ words
...drug monitoring, today announced the National Institutes of Health (NIH) has further recognized...With the NIH grant, we will expedite clinical trials for Levoprin-ZG, helping to bring...and centers that comprise the NIH. Clinical trials for Norzyme's Levoprin-ZG product...